Authors ’ Reply to Tsivgoulis et al.: “Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A likelihood to Achieve No Evidence of Disease Activity or Harm Analysis”
Source: CNS Drugs - Category: Neurology Source Type: research
More News: Multiple Sclerosis | Neurology